IMRN: financial statements from SEC — TradeAlmanac

IMRN

Immuron Limited: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Revenue	7m	5m	2m	765,193
Cost of revenue	3m	2m	495,558	241,691
Gross profit	5m	3m	1m	523,502
Research and development	4m	5m	3m	657,715
Selling, general and administrative	4m	5m	4m	4m
Operating income	−5m	−6m	−4m	−3m
Pre-tax income	−5m	−7m	−4m	−3m
Net income	−5m	−7m	−4m	−3m
Earnings per share	−2.26	−3.04	−1.66	−1.25
Earnings per share, diluted	−2.26	−3.04	−1.66	−1.25

Balance sheet

Metric	Aug 18, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash and equivalents	—	3m	12m	17m	22m	25m
Receivables	—	2m	1m	417,420	—

Cash flow

Metric	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Operating cash flow	−6m	−6m	−3m	−3m
Capital expenditure	—	195	7,739	10,048
Investing cash flow	−3m	327,561	−3m	11,737
Financing cash flow

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)